Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation: Implications for Bleeding Risk and Prognosis

This publication has 22 references indexed in Scilit:

• Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: A review of the available evidence and practical suggestions for the clinician
  International Journal of Cardiology, 2008
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)
  European Heart Journal, 2007
• Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
  European Heart Journal, 2007
• ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
  Journal of the American College of Cardiology, 2006
• Management of atrial fibrillation
  Heart, 2006
• A review of the management of patients after percutaneous coronary intervention
  International Journal Of Clinical Practice, 2006
• Meta-Analysis of Trials Comparing Oral Anticoagulation and Aspirin versus Dual Antiplatelet Therapy after Coronary Stenting
  Cardiology, 2005
• Guidelines for Percutaneous Coronary Interventions
  European Heart Journal, 2005
• Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
  Journal of the American College of Cardiology, 2005
• Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation
  American Heart Journal, 2004